Skip to main content
. 2019 Apr 2;10(26):2515–2529. doi: 10.18632/oncotarget.26808

Table 2. Top-40 potential peptide-HLA complexes for top-15 candidate TSAs binding to HLA-A*02.

Gene Peptide IC50 (nM) Strong/weak binders
1 ACTL8 KMLEILFEL 2.18 strong binder
2 MIA LLAWAISPV 3.95 strong binder
3 ERVV-2 ALPSLNWFV 4.43 strong binder
4 MAGEB4 KVLEFLAKV 6.26 strong binder
5 ERVV-2 FLFLYLSLL 6.64 strong binder
6 CLPSL1 LLFFFLFLL 8.2 strong binder
7 DMBX1 RLADIILEA 8.34 strong binder
8 ERVV-2 YLSLLPMPL 8.94 strong binder
9 DMRT1 SLFPYYNNL 9.04 strong binder
10 C6orf15 GLFARSIGV 9.14 strong binder
11 CLPSL1 FLLFFFLFL 9.29 strong binder
12 ERVV-2 SLNWFVPLL 10.3 strong binder
13 MAGEB4 LLMPLLSVI 10.69 strong binder
14 DMRT1 MVIQDIPAV 12.04 strong binder
15 CT83 KLVELEHTL 12.24 strong binder
16 CLPSL1 LLFLLFFFL 14.63 strong binder
17 MIA YMAPDCRFL 14.71 strong binder
18 C6orf15 ALPEELSYL 14.79 strong binder
19 CLPSL1 MMLPQWLLL 17.12 strong binder
20 CLPSL1 MLPQWLLLL 17.88 strong binder
21 ERVV-2 YLLAEQGGV 18.37 strong binder
22 MAGEB4 GLLMPLLSV 20.03 strong binder
23 ERVV-2 FLYLSLLPM 20.03 strong binder
24 C6orf15 YLSSAAALA 20.58 strong binder
25 MAGEA6 YIFATCLGL 20.58 strong binder
26 ERVV-2 YILVRNFSL 25.27 strong binder
27 DMBX1 YLGVNMAPL 25.69 strong binder
28 PRDM13 KLYSRKYGL 28.01 strong binder
29 ERVV-2 SLANSAHQV 28.78 strong binder
30 DMBX1 GLAPASATL 32.24 strong binder
31 ERVV-2 KITYSTPPV 32.41 strong binder
32 CT83 ILNNFPHSI 32.94 strong binder
33 MAGEA6 FLWGPRALI 36.31 strong binder
34 CT83 YLLLASSIL 38.12 strong binder
35 C4orf51 ILLPFSPLT 42.94 strong binder
36 MAGEA6 KIWEELSVL 45.09 strong binder
37 PRDM13 GLLKYPESI 46.57 strong binder
38 ERVV-2 NLYTCINNI 49.16 strong binder
39 DMBX1 HMAATNNLV 52.74 weak binder
40 CT83 LLASSILCA 53.9 weak binder